FIGURE

Figure 5

ID
ZDB-FIG-250328-10
Publication
Besio et al., 2025 - The administration of exogenous HSP47 as a collagen specific therapeutic approach
Other Figures
All Figure Page
Back to All Figure Page
Figure 5

rHSP47 increases collagen secretion, reduces collagen overmodifications, and enhances collagen I deposition in the ECM.

(A) rHSP47 effect on collagen secretion was evaluated in osteogenesis imperfecta (OI) probands and control fibroblasts. Secreted collagen was quantified in the last 24-hour culture media of fibroblasts after 7 days of culture with or without a 4-hour rHSP47 pulse (0.5 μM) every other day. Biological replicates (n = 3) were performed. For each biological replicate, collagen was quantified in 3 different wells for each condition. Kruskal-Wallis (KW) test, KW = 17.93 (P = 0.0005 by overall test; asterisks indicate post hoc test results). (B) Collagen secretion kinetics was evaluated in proband 1 by incubating the cells for 4 hours with 3H-proline. Technical replicates (n = 3) were performed. (C) Representative SDS-urea-PAGE of 3H-labeled collagen extracted from the medium of control and OI probands’ fibroblasts treated for 16 hours with 0.5 μM rHSP47 or with placebo. Biological replicates (n = 3) were performed. (D) Tandem mass spectrometry data of collagen I extracted from culture media of control and proband fibroblasts to evaluate lysyl hydroxylation and lysine O-glycosylation along the collagen helix (n = 3, pooled). Hydroxylysine (Hyl), galactosyl-hydroxylysine (GHL), and glucosylgalactosyl-hydroxylysine (GGHL) sites were identified by the analysis. The ratio between the posttranslationally modified peptides and the total peptides is reported. Light gray bars show proband 3 and red bars show proband 3 rHSP47. (E) Circular dichroism spectra reveal the collagen triple helical signal as a positive peak at 222 nm and negative peak below 200 nm in all samples (n = 3). Proband 3 is shown in light gray and proband 3 rHSP47 is shown in red. (F) The amount of collagen incorporated into the ECM was evaluated by Picrosirius red staining in cells grown for 7 days in the absence or presence of a 0.5 μM rHSP47 4-hour pulse performed every other day. Biological replicates (n = 3) were performed. For each biological replicate, collagen was quantified in 3 different wells for each condition. (G) The amount of collagen incorporated into the ECM was evaluated in fibroblasts from probands with collagen I mutations as reported in F (n = 3). Error bars indicate SD. Mann-Whitney Wilcoxon test was applied. Kruskal-Wallis (KW) test was also applied to describe the secreted collagen by genotype. Statistical analyses are described in Supplemental Table 2. *P < 0.05; **P ≤ 0.01; ***P ≤ 0.001.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ JCI Insight